Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: Relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products

Journal of Pathology

Volumn 182, Issue 4, 1997, Pages 392-397

  Langlois, Neil E I ^a   Lamb, Justin ^a   Eremin, Oleg ^a   Heys, Steven D ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

apoptosis; bcl 2; colorectal neoplasia; immunohistochemistry; mitosis; prognosis; protein p53; proto oncogene product c myc

Indexed keywords

MYC PROTEIN; PROTEIN BCL 2; PROTEIN P53;

ADULT; APOPTOSIS; ARTICLE; COLORECTAL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; AGE OF ONSET; APOPTOSIS; CELL COUNT; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MITOSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030742170     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199708)182:4<392::AID-PATH874>3.0.CO;2-G     Document Type: Article

References (36)

1. Anon. Scottish Health Statistics. Edinburgh: Information & Statistics Division. Directorate of Information Services. The National Health Senvice in Edinburgh, 1993.
2. Heys SD, O'Hanrahan TJ, Brittenden J, Eremin O. Colorectal cancer in young patients: a review of the literature. Eur J Surg Oncol 1994; 20: 225-231.
3. Tempero M, Anderson J. Progress in colon cancer - do molecular markers matter? N Engl J Med 1994; 331: 267-268.
4. Wyllie AH. Apoptosis (The 1992 Frank Rose Memorial Lecture). Br J Cancer 1993; 67: 205-208.
5. Baretton GB, Diebold J, Christoforis G, et al. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Cancer 1996; 77: 255-264.
6. Aihara M, Scardino PT, Truong LD, et al. The frequency of apoptosis correlates with the prognosis of Gleason grade 3 adenocarcinoma of the prostate. Cancer 1995; 75: 522-529.
7. Lipponen PK, Aaltomaa S. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. J Pathol 1994; 173: 333-339.
8. Lipponen P, Aaltomaa S, Kosma V-M, Syrjänen K. Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 1994; 30A: 2068-2073.
9. Leoncini L, del Vecchio MT, Megha T, et al. Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am J Pathol 1993; 142: 755-763.
10. Scott N, Martin I, Jack AS, Dixon MF, Quirke P. Genes mediating programmed cell death: an immunohistochemical study of bcl-2, c-myc and p53 expression in colorectal neoplasia. J Clin Pathol: Mol Pathol 1996; 49: M151-M158.
11. Heys SD, Sherif A, Bagley JS, Brittenden J. Smart C, Eremin O. Prognostic factors and survival of patients aged less than 45 years with colorectal cancer. Br J Surg 1994; 81: 685-688.
12. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251-306.
13. Hall PA, Coales PJ, Ansari B, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoplosis. J Cell Sci 1994; 107: 3569-3577.
14. Wheater PR, Burkitt HG, Daniel VG. Functional Histology. Edinburgh: Churchill Livingstone, 1979: 21-22.
15. King KL, Cidlowski JA. Cell cycle and apoptosis: common pathways to life and death. J Cell Biochem 1995; 58: 175-180.
16. Hall PA, Coates PJ. Assessment of cell proliferation in pathology - what next? Histopathology 1995; 26: 105-112.
17. Langlois NEI, King G, Herriott, Thompson WD. Non-enzymatic retrieval of antigen permits staining of follicle centre cells by the rabbit polyclonal antibody to protein gene product 9.5. J Pathol 1994; 173: 249-253.
18. Baas IO, Mulder J-WR, Offerhaus GJA, Vogelstein B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994; 172: 5-12.
19. Marra G, Boland CR. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and the historical perspectives. J Natl Cancer Inst 1995; 87: 1114-1125.
20. Steele GG. Growth Kinetics of Tumours. Oxford: Clarendon Press, 1977: 70, 175-176.
21. Cunningham D, Findlay M. The chemotherapy of colon cancer can no longer be ignored. Eur J Cancer 1993; 29A: 2077-2079.
22. Raff MC. Social controls on cell survival and cell death. Nature 1992: 356: 397-400.
23. Wyllie AH, Rose KA, Morris RG, Steel CM, Foster E, Spandidos DA. Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression. Br J Cancer 1987; 56: 251-259.
24. Yang C, Cirielli C, Capogrossi MC, Passaniti A. Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells. Cancer Res 1995; 55: 4210-4213.
25. Dowell SP, Hall PA. The p53 tumour suppressor gene and tumour prognosis: is there a relationship? J Pathol 1994; 172: 221-224.
26. Hall PA, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry? - revisited! J Pathol 1994; 172: 1-4.
27. DePinho RA, Schreiber-Agus N, Alt FW. myc family oncogenes in the development of normal and neoplastic cells. Adv Cancer Res 1991; 57: 1-46.
28. Jones DJ, Ghosh AK, Moore M, Schofield PF. A critical appraisal of the immunohistochemical detection of c-myc oncogene product in colorectal cancer. Br J Cancer 1987; 56: 779-783.
29. Galaktionov K, Chen X, Beach D. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 1996; 382: 511-517.
30. Evan GI, Wyllie AH, Gilbert CS, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 119-128.
31. Kaklamanis L, Savage A, Mortensen N, et al. Early expression of bcl-2 protein in the adenoma-carcinoma sequence of colorectal neoplasia. J Pathol 1996; 179: 10-14.
32. Hoehner JC, Hedborg F, Jernberg Wiklud H, Olsen L, Påhlman S. Cellular death in neuroblastoma: in situ correlation of apoptosis and bcl-2 expression. Int J Cancer 1995; 62: 19-24.
33. Törmänen U, Eerola A-K, Rainio P, et al. Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res 1995; 55: 5595-5602.
34. Evans DL, Tilby M, Dive C. Differential sensitivity to the induction of apoptosis by cisplatin in proliferating and quiescent immature rat thymocytes is independent of the levels of drug accumulation and DNA adduct formation. Cancer Res 1994; 54: 1596-1603.
35. Kubota Y, Petras RE, Easley KA, Bauer TW, Tubbs RR, Fazio VW. Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. Cancer 1992; 70: 2602-2609.
36. Lazaris AC, Davaris P, Nakopoulou L, Theodoropoulos GE, Koullias G, Golematis BC. Correlation between immunohistochemical expression of proliferating cell nuclear antigen and flow cytometry parameters in colorectal neoplasia. Dis Colon Rectum 1994; 37: 1083-1089.